| A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors (NCT04567615) | Bristol-Myers Squibb | 2021-02-04 |
| Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery (NCT04920019) | Mahidol University | 2020-10-22 |
| Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma (NCT04310709) | Asan Medical Center | 2020-06-16 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies (NCT03941626) | Shenzhen BinDeBio Ltd. | 2019-09-01 |
| HepATocellular Cancer Hcv Therapy Study (NCT04546802) | Bayside Health | 2019-09-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
| A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma (NCT02460991) | Boston Scientific Corporation | 2015-11-01 |
| Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery (NCT02174575) | Tokyo Medical and Dental University | 2014-07-01 |
| Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma (NCT02191878) | Arbutus Biopharma Corporation | 2014-06-01 |
| Sorafenib and TRC105 in Hepatocellular Cancer (NCT01306058) | National Cancer Institute (NCI) | 2011-02-11 |
| Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy (NCT01236690) | Changhai Hospital | 2010-11-01 |
| IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread (NCT01099631) | Masonic Cancer Center, University of Minnesota | 2010-04-01 |
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (NCT01298284) | Taipei Veterans General Hospital, Taiwan | 2009-10-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (NCT00844883) | Yale University | 2009-02-01 |
| A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® (NCT00877136) | St. Joseph Hospital of Orange | 2009-02-01 |
| Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma (NCT00861783) | Traws Pharma, Inc. | 2008-06-01 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (NCT00568308) | Progen Pharmaceuticals | 2007-12-01 |
| Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma (NCT00539643) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma (NCT00503867) | Sirtex Medical | 2007-07-18 |
| Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option (NCT00740753) | OHSU Knight Cancer Institute | 2004-08-01 |
| Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver (NCT00290316) | Central Texas Veterans Health Care System | 2004-07-01 |